共 50 条
- [31] Prostate cancer progression and survival in BRCA2 mutation carriersJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12): : 929 - 935Tryggvadottir, LaufeyVidarsdottir, LindaThorgeirsson, TryggviJonasson, Jon GunnlaugurOlafsdottir, Elinborg JonaOlafsdottir, Gudridur HelgaRafnar, ThorunnThorlacius, SteinunnJonsson, EirikurEyfjord, Jorunn ErlaTulinius, Hrafn
- [32] Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersEUROPEAN JOURNAL OF CANCER, 2023, 185 : 105 - 118Lozano, RebecaCastro, Elena-Campos, Fernando LopezThorne, HeatherRamirez-Backhaus, MiguelAragon, Isabel M.Cendon-Florez, YleniaGutierrez-Pecharroman, AnaSalles, Daniela C.Romero-Laorden, NuriaLorente, DavidGonzalez-Peramato, PilarCalatrava, AnaAlonso, ConcepcionAnido, UrbanoArevalo-Lobera, SaraBalmana, JudithChirivella, IsabelJuan-Fita, Maria JoseLlort, GemmaCajal, Teresa Ramon Y.Almagro, ElenaAlameda, DanielLopez-Casas, Pedro P.Herrera, BernardoMateo, JoaquinPritchard, Colin C.Antonarakis, Emmanuel S.Lotan, Tamara L.Rubio-Briones, JoseSandhu, ShahneenOlmos, David
- [33] BRCA1 and BRCA2 have a limited role in familial prostate cancerCANCER RESEARCH, 2000, 60 (05) : 1371 - 1375Sinclair, CSBerry, RSchaid, DThibodeau, SNCouch, FJ
- [34] Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyBJU INTERNATIONAL, 2011, 107 (01) : 28 - 39Mitra, Anita V.Bancroft, Elizabeth K.Barbachano, YolandaPage, Elizabeth C.Foster, C. S.Jameson, C.Mitchell, G.Lindeman, G. J.Stapleton, A.Suthers, G.Evans, D. G.Cruger, D.Blanco, I.Mercer, C.Kirk, J.Maehle, L.Hodgson, S.Walker, L.Izatt, L.Douglas, F.Tucker, K.Dorkins, H.Clowes, V.Male, A.Donaldson, A.Brewer, C.Doherty, R.Bulman, B.Osther, P. J.Salinas, M.Eccles, D.Axcrona, K.Jobson, I.Newcombe, B.Cybulski, C.Rubinstein, W. S.Buys, S.Townshend, S.Friedman, E.Domchek, S.Ramon y Cajal, T.Spigelman, A.Teo, S. H.Nicolai, N.Aaronson, N.Ardern-Jones, A.Bangma, C.Dearnaley, D.Eyfjord, J.Falconer, A.
- [35] Patients with prostate cancer and BRCA2 mutations need urgent treatmentBMJ-BRITISH MEDICAL JOURNAL, 2013, 346Torjesen, Ingrid
- [37] Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancerCLINICAL CANCER RESEARCH, 2007, 13 (03) : 839 - 843Agalliu, IlirKwon, Erika M.Zadory, DanielMcIntosh, LauraThompson, JosephStanford, Janet L.Ostrander, Elaine A.
- [38] The BRCA2 mutation status shapes the immune phenotype of prostate cancerCANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (10) : 1621 - 1633Jenzer, MaximilianKess, PeterNientiedt, CathleenEndris, VolkerKippenberger, MaximilianLeichsenring, JonasStoegbauer, FabianHaimes, JoshMishkin, SkylerKudlow, BrianKaczorowski, AdamZschaebitz, StefanieVolckmar, Anna-LenaSueltmann, HolgerJaeger, DirkDuensing, AnetteSchirmacher, PeterHohenfellner, MarkusGruellich, CarstenStenzinger, AlbrechtDuensing, Stefan
- [39] Re:: Prostate cancer progression and survival in BRCA2 mutation carriersEUROPEAN UROLOGY, 2007, 52 (05) : 1529 - 1529Boormans, Joost L.Schroeder, Fritz H.
- [40] The BRCA2 mutation status shapes the immune phenotype of prostate cancerCancer Immunology, Immunotherapy, 2019, 68 : 1621 - 1633Maximilian JenzerPeter KeßCathleen NientiedtVolker EndrisMaximilian KippenbergerJonas LeichsenringFabian StögbauerJosh HaimesSkyler MishkinBrian KudlowAdam KaczorowskiStefanie ZschäbitzAnna-Lena VolckmarHolger SültmannDirk JägerAnette DuensingPeter SchirmacherMarkus HohenfellnerCarsten GrüllichAlbrecht StenzingerStefan Duensing